The targeting construct introduced the point mutations resulting in the amino acid substitution of leucine with histidine at position 304 (L304H). Cre-mediated recombination removed the floxed neomycin resistance cassette within intron 9. (J:222898)
查看原文 参与反馈
The targeting construct introduced the point mutations resulting in the amino acid substitution of leucine with histidine at position 304 (L304H). Cre-mediated recombination removed the floxed neomycin resistance cassette within intron 9. (J:222898)